Kimberly Clark (KMB) AI Stock Analysis

• Market Cap: $44.53B
• Dividend Yield: 3.8%
• Average Volume (3M): 2.26M
• Price to Earnings (P/E): 18.4
• Beta (1Y): 0.12
• Revenue Growth: -6.89%
• EPS Growth: 7.52%
• Country: US
• Employees: 38,000
• Sector: Consumer Defensive
• Sector Strength: 52
• Industry: Household & Personal Products
• EPS (TTM): 1.92
• Shares Outstanding: 331,779,940
• 10 Day Avg. Volume: 2,639,154
• 30 Day Avg. Volume: 2,261,423
• PEG Ratio: 0.38
• Price to Book (P/B): 52.57
• Price to Sales (P/S): 2.20
• P/FCF Ratio: 17.57
• Enterprise Value/Market Cap: 1.12
• Enterprise Value/Revenue: 2.63
• Enterprise Value/Gross Profit: 7.48
• Enterprise Value/Ebitda: 12.78
• 1Y Price Target: $143.58
• Price Target Upside: 6.98% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 61 Neutral
• Price Target: $142.00 ▲(5.80% Upside)

Kimberly Clark's overall stock score reflects strong valuation and positive corporate events, offset by financial performance challenges and mixed technical indicators. The company's strategic initiatives and product innovations offer potential for future growth, but high leverage and tariff impacts remain concerns.

Positive Factors

Innovation and Growth

The company's initiatives and innovations are projected to drive organic sales growth, exceeding underlying market growth rates.

Market Share Growth

Kimberly Clark is expected to see continued momentum with market share gains and strong growth in China and other international markets.

Strategic Initiatives

The strategic decision to form a joint venture with Suzano is viewed positively, allowing a focus on higher growth and margin businesses.

Negative Factors

Earnings Guidance

Sales guidance lowered due to weakening consumer and category health.

Profitability Concerns

Profit guidance was reduced due to incremental $300M of gross costs associated with tariffs.

Tariffs Impact

Tariffs pose a meaningful profit headwind, with a $200M impact on net incremental tariff costs.

Kimberly Clark Business Overview & Revenue Model

Company Description

Kimberly-Clark Corporation is a global leader in the personal care and consumer products industry, operating in sectors such as personal care, consumer tissue, and professional products. The company is renowned for its strong portfolio of trusted brands, including Huggies, Kleenex, Scott, Kotex, and Depend, which are distributed in more than 175 countries. Kimberly-Clark's products are designed to enhance health, hygiene, and well-being for people around the world, making it a household name across various markets.

How the Company Makes Money

Kimberly-Clark makes money primarily through the manufacture and sale of personal care and consumer tissue products. The company's revenue model is centered on its strong brand portfolio, which includes leading names in diapers, tissues, and feminine care products. Kimberly-Clark generates revenue from multiple channels, including retail sales through supermarkets, drugstores, and other retail outlets, as well as direct sales to businesses and institutions in its professional segment. Key revenue streams include consumer tissue products such as Kleenex tissues and Scott paper towels, personal care items like Huggies diapers and Kotex feminine products, and professional health and hygiene products. The company also benefits from strategic partnerships and collaborations with retailers and distributors to expand its market reach and optimize its supply chain efficiencies.

Kimberly Clark Financial Statement Overview

Summary

Kimberly Clark shows strong profitability margins but faces challenges with declining revenue growth and high leverage. The company's cash flow generation remains adequate, but the decrease in free cash flow growth and high debt levels pose potential risks.

Income Statement

Kimberly Clark's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate by 4.39%, which is concerning. However, the company maintains a healthy gross profit margin of 35.21% and a net profit margin of 12.87%. The EBIT and EBITDA margins are also solid at 16.12% and 20.61%, respectively, indicating stable profitability despite revenue challenges.

Balance Sheet

The balance sheet reveals high leverage with a debt-to-equity ratio of 5.70 in the TTM period, which is a potential risk. Return on equity has decreased to 2.16%, reflecting lower profitability on shareholders' equity. The equity ratio stands at 7.58%, indicating a low proportion of equity financing, which could be a concern for financial stability.

Cash Flow

Cash flow analysis shows a decline in free cash flow growth by 12.12% in the TTM period, which is a negative indicator. However, the company maintains a reasonable operating cash flow to net income ratio of 0.40 and a free cash flow to net income ratio of 0.73, suggesting adequate cash generation relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	18.88B	20.06B	20.43B	20.18B	19.44B	19.14B
Gross Profit	6.65B	7.18B	7.03B	6.22B	5.99B	6.82B
EBITDA	3.89B	3.98B	3.07B	3.38B	3.25B	3.98B
Net Income	2.43B	2.54B	1.76B	1.93B	1.81B	2.35B
Balance Sheet
Total Assets	16.77B	16.55B	17.34B	17.97B	17.84B	17.52B
Cash, Cash Equivalents and Short-Term Investments	634.00M	1.02B	1.09B	427.00M	270.00M	303.00M
Total Debt	7.24B	7.92B	8.11B	8.42B	8.57B	8.36B
Total Liabilities	15.37B	15.57B	16.28B	17.27B	17.10B	16.65B
Stockholders Equity	1.27B	840.00M	915.00M	547.00M	514.00M	626.00M
Cash Flow
Free Cash Flow	2.10B	2.51B	2.78B	1.86B	1.72B	2.51B
Operating Cash Flow	2.87B	3.23B	3.54B	2.73B	2.73B	3.73B
Investing Cash Flow	-36.00M	-100.00M	-418.00M	-785.00M	-1.06B	-2.31B
Financing Cash Flow	-3.35B	-3.17B	-2.37B	-1.76B	-1.70B	-1.57B

Kimberly Clark Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 134.21
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KMB, the sentiment is Positive. The current price of 134.21 is above the 20-day moving average (MA) of 128.56, above the 50-day MA of 131.45, and above the 200-day MA of 132.64, indicating a bullish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 62.64 is Neutral, neither overbought nor oversold. The STOCH value of 81.95 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KMB.

Kimberly Clark Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PG	73 Outperform	$352.55B	23.16	31.23%	2.74%	0.29%	7.86%
CLX	71 Outperform	$15.45B	19.05	249.61%	3.89%	0.16%	191.17%
KVUE	70 Outperform	$41.55B	39.46	10.22%	3.80%	-1.18%	-29.18%
CHD	64 Neutral	$22.20B	42.99	12.07%	1.23%	1.13%	-34.78%
Sector *	63 Neutral	$20.31B	12.53	-7.33%	3.14%	2.97%	-12.13%
CL	63 Neutral	$67.13B	23.35	705.21%	2.46%	0.05%	3.55%
KMB	61 Neutral	$44.53B	18.35	196.26%	3.80%	-6.89%	7.52%

Kimberly Clark Corporate Events

Kimberly-Clark Announces Joint Venture with Suzano

On June 5, 2025, Kimberly-Clark announced a strategic joint venture with Suzano S.A., involving the company’s former International Family Care and Professional segment. This venture, where Suzano will hold a 51% interest, represents a significant operational shift for Kimberly-Clark, impacting its financial results as the IFP Business is now reported as discontinued operations.

The most recent analyst rating on (KMB) stock is a Hold with a $153.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.

Kimberly-Clark Forms Joint Venture with Suzano

On June 5, 2025, Kimberly-Clark announced a strategic partnership with Suzano to form a joint venture focusing on consumer tissue and professional products. This venture will include most of Kimberly-Clark’s International Family Care and Professional business, with Suzano acquiring a 51% interest for approximately $1.7 billion. The transaction aims to enhance operational efficiency and market share, with Kimberly-Clark retaining a 49% stake. This move is expected to sharpen Kimberly-Clark’s focus on higher growth and margin segments, improve shareholder returns, and reduce exposure to volatile input costs. The transaction is anticipated to close in mid-2026, pending regulatory approvals.

The most recent analyst rating on (KMB) stock is a Hold with a $140.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.

Kimberly-Clark Transfers Stock Listing to Nasdaq

On May 19, 2025, Kimberly-Clark Corporation announced its decision to transfer the listing of its common stock from the New York Stock Exchange to Nasdaq, effective May 30, 2025. This strategic move includes amendments to the company’s By-Laws to align with Nasdaq’s requirements, potentially impacting the company’s operations and stock trading dynamics.

The most recent analyst rating on (KMB) stock is a Hold with a $153.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.

Kimberly-Clark Appoints New President and COO

On May 1, 2025, Kimberly-Clark Corporation appointed Russell Torres as President and Chief Operating Officer, entrusting him with the oversight of the company’s business segments and global functions. This strategic leadership change aims to bolster the company’s operational efficiency and market growth. Additionally, Jeffrey Melucci was elected as Chief Strategy, Business Development and Administrative Officer to enhance corporate strategy and development.